Optimal Control of the COVID-19 Pandemic with Non-pharmaceutical Interventions
暂无分享,去创建一个
A. Perkins | G. España | T. Perkins | A. Perkins | G. Espana
[1] Centers for Disease Control and Prevention CDC COVID-19 Response Team. Severe Outcomes Among Patients with Coronavirus Disease 2019 (COVID-19) — United States, February 12–March 16, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[2] M. Keeling,et al. Modeling Infectious Diseases in Humans and Animals , 2007 .
[3] Carl A. B. Pearson,et al. The effect of control strategies to reduce social mixing on outcomes of the COVID-19 epidemic in Wuhan, China: a modelling study , 2020, The Lancet Public Health.
[4] Nuno R. Faria,et al. The effect of human mobility and control measures on the COVID-19 epidemic in China , 2020, Science.
[5] J. Martin,et al. Births: Final Data for 2018. , 2019, National vital statistics reports : from the Centers for Disease Control and Prevention, National Center for Health Statistics, National Vital Statistics System.
[6] M. T. Sofonea,et al. Optimal COVID-19 epidemic control until vaccine deployment , 2020, medRxiv.
[7] Eunok Jung,et al. Optimal Tuberculosis Prevention and Control Strategy from a Mathematical Model Based on Real Data , 2014, Bulletin of mathematical biology.
[8] Yonatan H. Grad,et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.
[9] C. Murray. Forecasting COVID-19 impact on hospital bed-days, ICU-days, ventilator-days and deaths by US state in the next 4 months , 2020, medRxiv.
[10] Matt J Keeling,et al. Estimation of country-level basic reproductive ratios for novel Coronavirus (COVID-19) using synthetic contact matrices , 2020, medRxiv.
[11] M. Lipsitch,et al. Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period , 2020, Science.
[12] Julia E. Aledort,et al. Non-pharmaceutical public health interventions for pandemic influenza: an evaluation of the evidence base , 2007, BMC public health.
[13] S. Lindstrom,et al. First Case of 2019 Novel Coronavirus in the United States , 2020, The New England journal of medicine.
[14] Karline Soetaert,et al. Solving Differential Equations in R: Package deSolve , 2010 .
[15] M. Kraemer,et al. Preparedness and vulnerability of African countries against importations of COVID-19: a modelling study , 2020, The Lancet.
[16] Suzanne Lenhart,et al. Backward Bifurcation and Optimal Control in Transmission Dynamics of West Nile Virus , 2010, Bulletin of mathematical biology.
[17] Nita H. Shah,et al. Control Strategies to Curtail Transmission of COVID-19 , 2020, medRxiv.
[18] Eunha Shim,et al. Optimal strategies of social distancing and vaccination against seasonal influenza. , 2013, Mathematical biosciences and engineering : MBE.
[19] Peng Wu,et al. Impact assessment of non-pharmaceutical interventions against coronavirus disease 2019 and influenza in Hong Kong: an observational study , 2020, The Lancet Public Health.
[20] M. Postma,et al. An optimal control theory approach to non-pharmaceutical interventions , 2010, BMC infectious diseases.
[21] Tamara Pilishvili,et al. Geographic Differences in COVID-19 Cases, Deaths, and Incidence — United States, February 12–April 7, 2020 , 2020, MMWR. Morbidity and mortality weekly report.
[22] C. Whittaker,et al. Report 9: Impact of non-pharmaceutical interventions (NPIs) to reduce COVID19 mortality and healthcare demand , 2020 .
[23] Joshua B. Plotkin,et al. Optimal, near-optimal, and robust epidemic control , 2020, Communications Physics.
[24] G. Chowell,et al. Estimating the asymptomatic proportion of coronavirus disease 2019 (COVID-19) cases on board the Diamond Princess cruise ship, Yokohama, Japan, 2020 , 2020, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.
[25] A. Schuchat,et al. COVID-19: towards controlling of a pandemic , 2020, The Lancet.
[26] Facundo Piguillem,et al. Optimal Covid-19 Quarantine and Testing Policies , 2020, The Economic Journal.
[27] Oscar Patterson-Lomba,et al. Optimal timing for social distancing during an epidemic , 2020, medRxiv.
[28] A. Tse,et al. New York Times Coronavirus (Covid-19) Data in the United States , 2020 .
[29] The Lancet. COVID-19 in the USA: a question of time , 2020, The Lancet.
[30] Chandini Raina MacIntyre,et al. Mathematical assessment of the impact of non-pharmaceutical interventions on curtailing the 2019 novel Coronavirus , 2020, Mathematical Biosciences.
[31] A. Tatem,et al. Effect of non-pharmaceutical interventions for containing the COVID-19 outbreak in China , 2020, medRxiv.
[32] John T. Workman,et al. Optimal Control Applied to Biological Models , 2007 .
[33] S. Lenhart,et al. Modeling Optimal Intervention Strategies for Cholera , 2010, Bulletin of mathematical biology.
[34] Quentin J. Leclerc,et al. Quantifying the impact of physical distance measures on the transmission of COVID-19 in the UK , 2020, BMC Medicine.
[35] Wei Aun Yap,et al. Time-variant strategies for optimizing the performance of non-pharmaceutical interventions (NPIs) in protecting lives and livelihoods during the COVID-19 pandemic , 2020, medRxiv.
[36] G. Onder,et al. Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy. , 2020, JAMA.
[37] Anita Lerch,et al. Estimating unobserved SARS-CoV-2 infections in the United States , 2020, Proceedings of the National Academy of Sciences.
[38] James Watmough,et al. Further Notes on the Basic Reproduction Number , 2008 .
[39] S. Bhatt,et al. Report 13: Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries , 2020 .
[40] Jessica T Davis,et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak , 2020, Science.
[41] Michael Li,et al. Reconciling early-outbreak estimates of the basic reproductive number and its uncertainty: framework and applications to the novel coronavirus (SARS-CoV-2) outbreak , 2020, Journal of the Royal Society Interface.
[42] S. C. Mpeshe,et al. Optimal Control and Sensitivity Analysis of an Influenza Model with Treatment and Vaccination , 2011, Acta biotheoretica.
[43] David N. Fisman,et al. Mathematical modelling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada , 2020, Canadian Medical Association Journal.
[44] F. Agusto,et al. Optimal control strategies for dengue transmission in pakistan. , 2018, Mathematical biosciences.
[45] N. Lurie,et al. Developing Covid-19 Vaccines at Pandemic Speed. , 2020, The New England journal of medicine.
[46] N. G. Davies,et al. Effects of non-pharmaceutical interventions on COVID-19 cases, deaths, and demand for hospital services in the UK: a modelling study , 2020, The Lancet Public Health.
[47] R. Reiner,et al. Heterogeneous local dynamics revealed by classification analysis of spatially disaggregated time series data , 2018, bioRxiv.
[48] Abhishek Mallela. Optimal Control applied to a SEIR model of 2019-nCoV with social distancing , 2020, medRxiv.
[49] D. Fisman,et al. Mathematical modeling of COVID-19 transmission and mitigation strategies in the population of Ontario, Canada , 2020 .